Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-01

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' original application for a generic levocetirizine dihydrochloride product, an antihistamine indicated for allergic rhin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

ORIG AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)